Document is current
Any future updates will be listed below
-
Authors
Stadlbauer, Daniel https://orcid.org/0000-0001-6792-7650
Waal, Leon de
Beaulieu, Edith
Strohmeier, Shirin
Kroeze, Edwin J. B. Veldhuis
Boutet, Philippe
Osterhaus, Albert D. M. E.
Krammer, Florian https://orcid.org/0000-0003-4121-776X
Innis, Bruce L. https://orcid.org/0000-0002-1753-7248
Nachbagauer, Raffael https://orcid.org/0000-0001-5568-5420
Stittelaar, Koert J.
Mallett, Corey P. https://orcid.org/0000-0002-6232-8111
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (HHSO100201200013I, HHSO100201200013I)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI128821, R01 AI128821)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 6 September 2020
Accepted: 16 February 2021
First Online: 19 March 2021
Competing interests
: The following interests are relevant to the submitted work. E.B., P.B., B.L.I., and C.P.M. are, or were at the time of the study, employees of the GSK group of companies. P.B. and C.P.M. report ownership of GSK shares and/or restricted GSK shares. B.L.I. and C.P.M. are listed as an inventor on patents owned by the GSK group of companies. The remaining authors declare that there are no competing interests.
